ArticleHealth services research2014
HIV testing in the nation's opioid treatment programs, 2005-2011: the role of state regulations.
Article in Health services research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Bundling Rapid Human Immunodeficiency Virus and Hepatitis C Virus Testing to Increase Receipt of Test Results: A Randomized Trial.Medical care · 2020Trial
- Trial
- Cost-effectiveness of rapid hepatitis C virus (HCV) testing and simultaneous rapid HCV and HIV testing in substance abuse treatment programs.Addiction (Abingdon, England) · 2015Trial
- The role of opioid treatment programs' crisis response on client perceptions of risk and impact.BMC public health · 2025Article
- HIV and HCV Screening, and Pre-Exposure Prophylaxis Among Managed Care Beneficiaries with Substance Use Disorders: A Cross-Sectional Study from a Single State.Risk management and healthcare policy · 2025Article
- Workforce Diversity and disparities in wait time and retention among opioid treatment programs.Substance abuse treatment, prevention, and policy · 2022Article
- Patient-centered care's relationship with substance use disorder treatment utilization.Journal of substance abuse treatment · 2020Article
- Representative Bureaucracy Through Staff With Lived Experience: Peer Coproduction in the Field of Substance Use Disorder Treatment.American review of public administration · 2020Article
- Coproduction in the Treatment of Substance Use Disorder and Its Relationship to Clinics' Service Output Patterns.The Social service review · 2020Article
- Correlates of Patient-Centered Care Practices at U.S. Substance Use Disorder Clinics.Psychiatric services (Washington, D.C.) · 2020Article
- Evidence-based treatment for opioid use disorders: A national study of methadone dose levels, 2011-2017.Journal of substance abuse treatment · 2019Article
- Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda.Current HIV research · 2019Review
- Informing Targeted Interventions to Optimize the Cascade of HIV Care Using Cluster Analyses of Health Resource Use Among People Living with HIV/AIDS.AIDS and behavior · 2018Article
- Linkages Between Patient-centered Medical Homes and Addiction Treatment Organizations: Results From a National Survey.Medical care · 2017Article
- Factors Associated with HIV Testing Among Participants from Substance Use Disorder Treatment Programs in the US: A Machine Learning Approach.AIDS and behavior · 2017Article
- Does the Strategy of Risk Group Testing for Hepatitis C Hit the Target?Frontiers in pharmacology · 2017Article
- Spillover effects of HIV testing policies: changes in HIV testing guidelines and HCV testing practices in drug treatment programs in the United States.BMC public health · 2016Article
- Hepatitis C testing in substance use disorder treatment: the role of program managers in adoption of testing services.Substance abuse treatment, prevention, and policy · 2016Article
- Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.Journal of substance abuse treatment · 2016Article
- Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients.AIDS and behavior · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectiveTo identify the extent to which clients in a national sample of opioid treatment programs (OTPs) received HIV testing in 2005 and 2011; to examine relationships between state laws for informed consent and pretest counseling and rates of HIV testing among OTP clients. DATA SOURCE: Data were collected from a nationally representative sample of OTPs in 2005 (n = 171) and 2011 (n = 200). STUDY
designRandom-effects logit and interval regression analyses were used to examine changes in HIV testing rates and the relationship of state laws to HIV testing among OTPs. DATA COLLECTION: Data on OTP provision of HIV testing were collected in phone surveys from OTP managers; data also were collected on state laws for HIV testing. PRINCIPAL
findingsThe percentage of OTPs offering HIV testing decreased significantly from 93 percent in 2005 to 64 percent in 2011. Similarly, the percentage of clients tested decreased from an average of 41 percent in 2005 to 17 percent in 2011. OTPs located in states whose laws do not require pretest counseling and that use opt-out consent were more likely to provide HIV testing and to test higher percentages of clients.
conclusionsThe results show the need to increase HIV testing among OTP clients; the results also underscore the beneficial possibilities of dropping pretest counseling as a requirement for HIV testing and of using the opt-out approach to informed consent for testing.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.